DOCS (Doximity) Growth Rank: 9 (As of Jul. 03, 2026) — 10% Below Median


DOCS Doximity Inc DOCS
82 GF Score
Price $21.86
GF Value $49.24
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Doximity Growth Rank?

Doximity DOCS +1.25% 82 Growth Rank is 9 as of Jul. 03, 2026, which is 10% below its 10-year median of 10.00. GuruFocus rates DOCS with a GF Score™ of 82/100 and a GF Value™ of $49.24 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Doximity has the Growth Rank of 9.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

DOCS vs WAY, PRVA, HTFL: Growth Rank Comparison

For the Health Information Services subindustry, Doximity's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Doximity Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Doximity's Growth Rank distribution charts can be found below:

* The bar in red indicates where Doximity's Growth Rank falls into.


DOCS
82GF Score
Doximity Inc DOCS
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 9 mean?
Doximity (DOCS) has a Growth Rank of 9 as of Jul. 03, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Doximity and its competitors. This is 10% below median its historical median of 10.00. Over the past decade, Doximity's Growth Rank has ranged from 9.00 to 10.00.
Is Doximity's Growth Rank too high?
Doximity's current Growth Rank of 9 is 10% below median its 10-year median of 10.00. Over the past 10 years, this metric has ranged from a low of 9.00 to a high of 10.00. Overall, Doximity has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Doximity's Growth Rank compare to WAY and PRVA?
Doximity's Growth Rank of 9 can be compared against companies in the Healthcare Providers & Services industry. Historically, Doximity's own Growth Rank has ranged from 9.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Doximity and its competitors. Doximity's current Growth Rank is 9, which is 10% below median its own 10-year median of 10.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doximity stock overvalued right now?
Based on GuruFocus' analysis, Doximity (DOCS) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.24, compared to a current price of $21.86 — trading 55.6% below its estimated fair value. The current Growth Rank is 9, which is 10% below median its 10-year median of 10.00. Doximity's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Doximity (DOCS), the current Growth Rank is 9 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doximity (DOCS) Overvalued in 2026?

Based on GuruFocus' analysis, Doximity stock appears to be undervalued. The current stock price of $21.86 is trading 55.6% below its estimated GF Value™ of $49.24. GuruFocus considers Doximity to be Significantly Undervalued.

Key valuation signals for DOCS:

  • Growth Rank: 9 (10% below median its 10-year median of 10.00)
  • GF Value™: $49.24 vs. price of $21.86 (55.6% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the DOCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doximity Business Description

Other Exchanges D2OC34:Brazil
Address 500 3rd Street, Suite 510, San Francisco, CA, USA, 94107
Doximity Inc provides an online platform, which enables physicians and other healthcare professionals to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The Company's customers include pharmaceutical companies and health systems that connect with healthcare professionals through the Company's digital Marketing, Hiring, and Workflow Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential medical professional candidates.
82GF Score

Get the complete analysis for DOCS

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.86
Price
$49.24
GF Value